immunorepressive
bivatuzumab
RAT test
intetumumab
agonistic monoclonal antibody
histoantigen
immunodomination
-zumab
amlitelimab
heteroclitic
cergutuzumab
antinucleosome
neoantigen
multiantigen
ozogamicin
polyantibody
pathoantigen
antihuman
immunochemistry
immunosorbent
dinutuximab
radioimmunology
retifanlimab
sasanlimab
pozelimab
toripalimab
brolucizumab
ravulizumab
olaratumab
abagovomab
solitomab
zenocutuzumab
gevokizumab
ziltivekimab
vanucizumab
sintilimab
polyvalent
pidilizumab
tislelizumab
cibisatamab
antimouse
heterophile
glembatumumab
immunoprobe
immunohistopathologic